Michael Barbella, Managing Editor10.12.23
Body Vision Medical has signed exclusive distribution agreements with Prism Technologies Limited, Paragon Care, and Kral Medical Solutions to introduce its LungVision real-time, intraoperative computed tomography (CT) imaging system to Hong Kong, Macao and the entire Greater Bay Area (GBA), Australia and New Zealand, and Romania, respectively.
The artificial intelligence (AI)-powered LungVision System transforms X-ray images obtained from any C-arm device into real-time intraoperative CT scans. This technology empowers bronchoscopists to visualize pulmonary lesions in real-time and ensuring precise biopsy during diagnostic bronchoscopy. By enhancing the precision and accuracy of the lung nodule biopsy procedure through real-time image-guidance, LungVision can potentially enable an earlier cancer diagnosis and improve the long-term survival prospects of lung cancer patients.
"We view these partnerships as a pivotal stride towards democratizing Body Vision's LungVision and giving lung patients worldwide access to the latest in AI-powered imaging technology," Body Vision Medical CEO David Webster said. "In many parts of the world with high lung cancer incidence, limited access to advanced medical solutions has translated into lower patient survival rates. With innovative yet cost-effective solutions like LungVision, we hope to challenge and change that status quo."
In line with its growth strategy, Body Vision Medical aims to expand lung patient access to LungVision in 60 new markets within the next three years. With these strategic alliances in place, the company is poised to advance its mission of transforming lung cancer diagnosis and, potentially in the future, minimally-invasive, localized therapy delivery on a global scale.
Established in 2008, Prism Technologies Limited distributes medical products in Hong Kong, Macao and the entire Greater Bay Area (GBA). The company is a prominent player in the medical industry, empowering healthcare professionals and institutions with advanced technologies to enhance patient care and outcomes.
Paragon Care provides healthcare equipment, devices, and consumables and is one of the largest premier medical distributors for Australia and New Zealand. Leveraging their agility and extensive experience, Paragon Care ensures access to the right equipment in order to achieve optimal clinical outcomes.
With a portfolio of intelligent products, Kral Medical Solutions helps improve work processes within operating rooms and associated clinical areas, offering support to hospitals in delivering efficient and safe patient care. The company provides solutions applicable to various medical disciplines, including vascular surgery, neurosurgery, orthopedics, and traumatology.
Body Vision Medical specializes in AI-driven, intraoperative imaging. Its first commercial product, LungVision, addresses the unmet clinical need for early, definitive lung cancer diagnosis and, in the future, to enable effective treatment of lung lesions via a minimally-invasive procedure.
The artificial intelligence (AI)-powered LungVision System transforms X-ray images obtained from any C-arm device into real-time intraoperative CT scans. This technology empowers bronchoscopists to visualize pulmonary lesions in real-time and ensuring precise biopsy during diagnostic bronchoscopy. By enhancing the precision and accuracy of the lung nodule biopsy procedure through real-time image-guidance, LungVision can potentially enable an earlier cancer diagnosis and improve the long-term survival prospects of lung cancer patients.
"We view these partnerships as a pivotal stride towards democratizing Body Vision's LungVision and giving lung patients worldwide access to the latest in AI-powered imaging technology," Body Vision Medical CEO David Webster said. "In many parts of the world with high lung cancer incidence, limited access to advanced medical solutions has translated into lower patient survival rates. With innovative yet cost-effective solutions like LungVision, we hope to challenge and change that status quo."
In line with its growth strategy, Body Vision Medical aims to expand lung patient access to LungVision in 60 new markets within the next three years. With these strategic alliances in place, the company is poised to advance its mission of transforming lung cancer diagnosis and, potentially in the future, minimally-invasive, localized therapy delivery on a global scale.
Established in 2008, Prism Technologies Limited distributes medical products in Hong Kong, Macao and the entire Greater Bay Area (GBA). The company is a prominent player in the medical industry, empowering healthcare professionals and institutions with advanced technologies to enhance patient care and outcomes.
Paragon Care provides healthcare equipment, devices, and consumables and is one of the largest premier medical distributors for Australia and New Zealand. Leveraging their agility and extensive experience, Paragon Care ensures access to the right equipment in order to achieve optimal clinical outcomes.
With a portfolio of intelligent products, Kral Medical Solutions helps improve work processes within operating rooms and associated clinical areas, offering support to hospitals in delivering efficient and safe patient care. The company provides solutions applicable to various medical disciplines, including vascular surgery, neurosurgery, orthopedics, and traumatology.
Body Vision Medical specializes in AI-driven, intraoperative imaging. Its first commercial product, LungVision, addresses the unmet clinical need for early, definitive lung cancer diagnosis and, in the future, to enable effective treatment of lung lesions via a minimally-invasive procedure.